Loading…
Evaluation of visual recognition memory for the early diagnosis of Alzheimer's disease in patients over 75 years
Current diagnostic criteria of Alzheimer Disease (AD) are mainly based on clinical definition. In France, the Delayed Matching Sample (DMS48) test, a recently introduced test that explores visual object recognition, is recommended for the early diagnosis of AD. However, little is known on the DMS48...
Saved in:
Published in: | Revue neurologique 2012-06, Vol.168 (6-7), p.483-487 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c362t-6bd004a0e8a1a8fe0162a829b5ae0a52a329bf86a60443d85b2aa88e9c689c5e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c362t-6bd004a0e8a1a8fe0162a829b5ae0a52a329bf86a60443d85b2aa88e9c689c5e3 |
container_end_page | 487 |
container_issue | 6-7 |
container_start_page | 483 |
container_title | Revue neurologique |
container_volume | 168 |
creator | Poissonnet, A. Henry-Feugeas, M.-C. Drunat, O. Wolmark, Y. Delpierre, S. Koskas, P. |
description | Current diagnostic criteria of Alzheimer Disease (AD) are mainly based on clinical definition. In France, the Delayed Matching Sample (DMS48) test, a recently introduced test that explores visual object recognition, is recommended for the early diagnosis of AD. However, little is known on the DMS48 performances of older subjects over 75 years. Therefore, our aim was to assess its specific clinical value for early detection of AD in older patients.
We studied 93 consecutive patients over 75 years from an expert memory clinic in a geriatric hospital. This population included 31 patients with single domain amnestic Mild Cognitive Impairment (aMCI), 31 AD patients and 31 controls subjects.
The aMCI and AD performances on the DMS48 were significantly lower than those of the control subjects (set 1 and set 2, P |
doi_str_mv | 10.1016/j.neurol.2011.11.004 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1022377362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S003537871200625X</els_id><sourcerecordid>1022377362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-6bd004a0e8a1a8fe0162a829b5ae0a52a329bf86a60443d85b2aa88e9c689c5e3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRb0A0VL4A4S8g02L47zcDVJVlYdUiQ2srUkyaV0lcbCTSOXrmdLCEmkkW-N7Z3wPYzeBmAUiSB52swZ7Z6uZFEEwoxIiOmNjIcJ4GqYqHbFL73dCyCAV4QUbSRmJOIrVmLWrAaoeOmMbbks-GN9DxR3mdtOYn26NtXV7XlrHuy1yBFfteWFg01hv_MG0qL62aGp0d54ePIJHbhre0lRsOpIM6Hga8z15_RU7L6HyeH06J-zjafW-fJmu355fl4v1NA8T2U2TrKAMIFBBAKpESilByXkWAwqIJYR0L1UCiYiisFBxJgGUwnmeqHkeYzhh98e5rbOfPfpO18bnWFXQoO29DoSUYZrSMpJGR2nurPcOS906U4Pbk0gf-OqdPvLVB76aiv5GttvThj6rsfgz_cIlweNRgJRzMOi0z4lIjoUhwJ0urPl_wzcgN5FO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1022377362</pqid></control><display><type>article</type><title>Evaluation of visual recognition memory for the early diagnosis of Alzheimer's disease in patients over 75 years</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Poissonnet, A. ; Henry-Feugeas, M.-C. ; Drunat, O. ; Wolmark, Y. ; Delpierre, S. ; Koskas, P.</creator><creatorcontrib>Poissonnet, A. ; Henry-Feugeas, M.-C. ; Drunat, O. ; Wolmark, Y. ; Delpierre, S. ; Koskas, P.</creatorcontrib><description>Current diagnostic criteria of Alzheimer Disease (AD) are mainly based on clinical definition. In France, the Delayed Matching Sample (DMS48) test, a recently introduced test that explores visual object recognition, is recommended for the early diagnosis of AD. However, little is known on the DMS48 performances of older subjects over 75 years. Therefore, our aim was to assess its specific clinical value for early detection of AD in older patients.
We studied 93 consecutive patients over 75 years from an expert memory clinic in a geriatric hospital. This population included 31 patients with single domain amnestic Mild Cognitive Impairment (aMCI), 31 AD patients and 31 controls subjects.
The aMCI and AD performances on the DMS48 were significantly lower than those of the control subjects (set 1 and set 2, P<10−7). The DMS48 performances in the healthy group appeared closely related to the previously published normative data. However, the DMS48 performances appeared unexpectedly high in these older patients, especially in the AD subgroup (set 1, 82.2±12.1 and set 2, 75.2±16.2). Moreover, there was an unexpected frequent discordance between the results on the DMS48 and the Free and Cued Selective Reminding tests (FCSR). The DMS test appears useful for highlighting the heterogeneity of the syndromes of aMCI and AD in old-old people aged 75+: our results also underline the need for further characterization of cognitive impairment in this fastest growing subgroup of patients.
Actuellement, les critères diagnostiques de la maladie d’Alzheimer (MA) sont principalement basés sur une définition clinique. En France, le delayed matching sample (DMS48) est désormais recommandé. Il s’agit d’un test récemment présenté qui explore la reconnaissance visuelle en vue d’un diagnostic précoce de la MA. Cependant, on connaît encore peu les performances à ce test des patients âgés de plus de 75ans. Notre but est donc d’évaluer la valeur clinique de ce test pour un diagnostic précoce des patients de plus de 75ans.
Nous avons étudié 93 patients consécutifs de plus de 75ans dans le cadre d’une consultation mémoire au sein d’un hôpital gériatrique. Ont été inclus 31 patients présentant un déclin cognitif léger touchant uniquement la mémoire (aMCI), 31 patients présentant une MA et 31 sujets témoins.
Les résultats au DMS48 des patients aMCI et des patients atteints de MA sont significativement plus faibles que ceux des sujets témoins (set 1 et set 2, p<10−7). Les performances au DMS48 du groupe témoin sont apparues étroitement liées aux données normatives précédemment publiées. Cependant, les performances des patients âgés sont étonnamment plus élevés que les performances attendues des patients jeunes et particulièrement dans le groupe des patients atteints de MA (set 1, 82,2±12,1 et set 2 75,2±16,2). De plus, il y a également une discordance inattendue entre les résultats au DMS48 et au Grober et Buschke RL/RI 16 items. Le DMS48 apparaît utile pour mettre en évidence l’hétérogénéité des syndromes amnésiques des patients MCI et des patients atteints de MA, notamment chez les patients âgées de plus de 75ans : nos résultats soulignent le besoin de la nouvelle caractérisation des troubles cognitifs qui sont de nos jours en croissance au vu de la population vieillissante.</description><identifier>ISSN: 0035-3787</identifier><identifier>DOI: 10.1016/j.neurol.2011.11.004</identifier><identifier>PMID: 22405458</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Aged ; Aged, 80 and over ; Alzheimer disease (AD) ; Alzheimer Disease - diagnosis ; Alzheimer Disease - psychology ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - psychology ; Delayed matching sample ; DMS 48 ; Early Diagnosis ; Educational Status ; Elderly people ; Female ; Free and cued selective reminding test ; Grober et Buschke RL/RI 16 items ; Humans ; Maladie d’Alzheimer ; Male ; Memory - physiology ; Mental Recall - physiology ; Mild cognitive impairment (MCI) ; Neuropsychological Tests ; Patients âgés ; Recognition (Psychology) - physiology ; Reproducibility of Results ; Trouble cognitif léger ; Visual Perception - physiology</subject><ispartof>Revue neurologique, 2012-06, Vol.168 (6-7), p.483-487</ispartof><rights>2012 Elsevier Masson SAS</rights><rights>Copyright © 2012 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-6bd004a0e8a1a8fe0162a829b5ae0a52a329bf86a60443d85b2aa88e9c689c5e3</citedby><cites>FETCH-LOGICAL-c362t-6bd004a0e8a1a8fe0162a829b5ae0a52a329bf86a60443d85b2aa88e9c689c5e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22405458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poissonnet, A.</creatorcontrib><creatorcontrib>Henry-Feugeas, M.-C.</creatorcontrib><creatorcontrib>Drunat, O.</creatorcontrib><creatorcontrib>Wolmark, Y.</creatorcontrib><creatorcontrib>Delpierre, S.</creatorcontrib><creatorcontrib>Koskas, P.</creatorcontrib><title>Evaluation of visual recognition memory for the early diagnosis of Alzheimer's disease in patients over 75 years</title><title>Revue neurologique</title><addtitle>Rev Neurol (Paris)</addtitle><description>Current diagnostic criteria of Alzheimer Disease (AD) are mainly based on clinical definition. In France, the Delayed Matching Sample (DMS48) test, a recently introduced test that explores visual object recognition, is recommended for the early diagnosis of AD. However, little is known on the DMS48 performances of older subjects over 75 years. Therefore, our aim was to assess its specific clinical value for early detection of AD in older patients.
We studied 93 consecutive patients over 75 years from an expert memory clinic in a geriatric hospital. This population included 31 patients with single domain amnestic Mild Cognitive Impairment (aMCI), 31 AD patients and 31 controls subjects.
The aMCI and AD performances on the DMS48 were significantly lower than those of the control subjects (set 1 and set 2, P<10−7). The DMS48 performances in the healthy group appeared closely related to the previously published normative data. However, the DMS48 performances appeared unexpectedly high in these older patients, especially in the AD subgroup (set 1, 82.2±12.1 and set 2, 75.2±16.2). Moreover, there was an unexpected frequent discordance between the results on the DMS48 and the Free and Cued Selective Reminding tests (FCSR). The DMS test appears useful for highlighting the heterogeneity of the syndromes of aMCI and AD in old-old people aged 75+: our results also underline the need for further characterization of cognitive impairment in this fastest growing subgroup of patients.
Actuellement, les critères diagnostiques de la maladie d’Alzheimer (MA) sont principalement basés sur une définition clinique. En France, le delayed matching sample (DMS48) est désormais recommandé. Il s’agit d’un test récemment présenté qui explore la reconnaissance visuelle en vue d’un diagnostic précoce de la MA. Cependant, on connaît encore peu les performances à ce test des patients âgés de plus de 75ans. Notre but est donc d’évaluer la valeur clinique de ce test pour un diagnostic précoce des patients de plus de 75ans.
Nous avons étudié 93 patients consécutifs de plus de 75ans dans le cadre d’une consultation mémoire au sein d’un hôpital gériatrique. Ont été inclus 31 patients présentant un déclin cognitif léger touchant uniquement la mémoire (aMCI), 31 patients présentant une MA et 31 sujets témoins.
Les résultats au DMS48 des patients aMCI et des patients atteints de MA sont significativement plus faibles que ceux des sujets témoins (set 1 et set 2, p<10−7). Les performances au DMS48 du groupe témoin sont apparues étroitement liées aux données normatives précédemment publiées. Cependant, les performances des patients âgés sont étonnamment plus élevés que les performances attendues des patients jeunes et particulièrement dans le groupe des patients atteints de MA (set 1, 82,2±12,1 et set 2 75,2±16,2). De plus, il y a également une discordance inattendue entre les résultats au DMS48 et au Grober et Buschke RL/RI 16 items. Le DMS48 apparaît utile pour mettre en évidence l’hétérogénéité des syndromes amnésiques des patients MCI et des patients atteints de MA, notamment chez les patients âgées de plus de 75ans : nos résultats soulignent le besoin de la nouvelle caractérisation des troubles cognitifs qui sont de nos jours en croissance au vu de la population vieillissante.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer disease (AD)</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - psychology</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - psychology</subject><subject>Delayed matching sample</subject><subject>DMS 48</subject><subject>Early Diagnosis</subject><subject>Educational Status</subject><subject>Elderly people</subject><subject>Female</subject><subject>Free and cued selective reminding test</subject><subject>Grober et Buschke RL/RI 16 items</subject><subject>Humans</subject><subject>Maladie d’Alzheimer</subject><subject>Male</subject><subject>Memory - physiology</subject><subject>Mental Recall - physiology</subject><subject>Mild cognitive impairment (MCI)</subject><subject>Neuropsychological Tests</subject><subject>Patients âgés</subject><subject>Recognition (Psychology) - physiology</subject><subject>Reproducibility of Results</subject><subject>Trouble cognitif léger</subject><subject>Visual Perception - physiology</subject><issn>0035-3787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRb0A0VL4A4S8g02L47zcDVJVlYdUiQ2srUkyaV0lcbCTSOXrmdLCEmkkW-N7Z3wPYzeBmAUiSB52swZ7Z6uZFEEwoxIiOmNjIcJ4GqYqHbFL73dCyCAV4QUbSRmJOIrVmLWrAaoeOmMbbks-GN9DxR3mdtOYn26NtXV7XlrHuy1yBFfteWFg01hv_MG0qL62aGp0d54ePIJHbhre0lRsOpIM6Hga8z15_RU7L6HyeH06J-zjafW-fJmu355fl4v1NA8T2U2TrKAMIFBBAKpESilByXkWAwqIJYR0L1UCiYiisFBxJgGUwnmeqHkeYzhh98e5rbOfPfpO18bnWFXQoO29DoSUYZrSMpJGR2nurPcOS906U4Pbk0gf-OqdPvLVB76aiv5GttvThj6rsfgz_cIlweNRgJRzMOi0z4lIjoUhwJ0urPl_wzcgN5FO</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Poissonnet, A.</creator><creator>Henry-Feugeas, M.-C.</creator><creator>Drunat, O.</creator><creator>Wolmark, Y.</creator><creator>Delpierre, S.</creator><creator>Koskas, P.</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Evaluation of visual recognition memory for the early diagnosis of Alzheimer's disease in patients over 75 years</title><author>Poissonnet, A. ; Henry-Feugeas, M.-C. ; Drunat, O. ; Wolmark, Y. ; Delpierre, S. ; Koskas, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-6bd004a0e8a1a8fe0162a829b5ae0a52a329bf86a60443d85b2aa88e9c689c5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer disease (AD)</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - psychology</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - psychology</topic><topic>Delayed matching sample</topic><topic>DMS 48</topic><topic>Early Diagnosis</topic><topic>Educational Status</topic><topic>Elderly people</topic><topic>Female</topic><topic>Free and cued selective reminding test</topic><topic>Grober et Buschke RL/RI 16 items</topic><topic>Humans</topic><topic>Maladie d’Alzheimer</topic><topic>Male</topic><topic>Memory - physiology</topic><topic>Mental Recall - physiology</topic><topic>Mild cognitive impairment (MCI)</topic><topic>Neuropsychological Tests</topic><topic>Patients âgés</topic><topic>Recognition (Psychology) - physiology</topic><topic>Reproducibility of Results</topic><topic>Trouble cognitif léger</topic><topic>Visual Perception - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poissonnet, A.</creatorcontrib><creatorcontrib>Henry-Feugeas, M.-C.</creatorcontrib><creatorcontrib>Drunat, O.</creatorcontrib><creatorcontrib>Wolmark, Y.</creatorcontrib><creatorcontrib>Delpierre, S.</creatorcontrib><creatorcontrib>Koskas, P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Revue neurologique</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poissonnet, A.</au><au>Henry-Feugeas, M.-C.</au><au>Drunat, O.</au><au>Wolmark, Y.</au><au>Delpierre, S.</au><au>Koskas, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of visual recognition memory for the early diagnosis of Alzheimer's disease in patients over 75 years</atitle><jtitle>Revue neurologique</jtitle><addtitle>Rev Neurol (Paris)</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>168</volume><issue>6-7</issue><spage>483</spage><epage>487</epage><pages>483-487</pages><issn>0035-3787</issn><abstract>Current diagnostic criteria of Alzheimer Disease (AD) are mainly based on clinical definition. In France, the Delayed Matching Sample (DMS48) test, a recently introduced test that explores visual object recognition, is recommended for the early diagnosis of AD. However, little is known on the DMS48 performances of older subjects over 75 years. Therefore, our aim was to assess its specific clinical value for early detection of AD in older patients.
We studied 93 consecutive patients over 75 years from an expert memory clinic in a geriatric hospital. This population included 31 patients with single domain amnestic Mild Cognitive Impairment (aMCI), 31 AD patients and 31 controls subjects.
The aMCI and AD performances on the DMS48 were significantly lower than those of the control subjects (set 1 and set 2, P<10−7). The DMS48 performances in the healthy group appeared closely related to the previously published normative data. However, the DMS48 performances appeared unexpectedly high in these older patients, especially in the AD subgroup (set 1, 82.2±12.1 and set 2, 75.2±16.2). Moreover, there was an unexpected frequent discordance between the results on the DMS48 and the Free and Cued Selective Reminding tests (FCSR). The DMS test appears useful for highlighting the heterogeneity of the syndromes of aMCI and AD in old-old people aged 75+: our results also underline the need for further characterization of cognitive impairment in this fastest growing subgroup of patients.
Actuellement, les critères diagnostiques de la maladie d’Alzheimer (MA) sont principalement basés sur une définition clinique. En France, le delayed matching sample (DMS48) est désormais recommandé. Il s’agit d’un test récemment présenté qui explore la reconnaissance visuelle en vue d’un diagnostic précoce de la MA. Cependant, on connaît encore peu les performances à ce test des patients âgés de plus de 75ans. Notre but est donc d’évaluer la valeur clinique de ce test pour un diagnostic précoce des patients de plus de 75ans.
Nous avons étudié 93 patients consécutifs de plus de 75ans dans le cadre d’une consultation mémoire au sein d’un hôpital gériatrique. Ont été inclus 31 patients présentant un déclin cognitif léger touchant uniquement la mémoire (aMCI), 31 patients présentant une MA et 31 sujets témoins.
Les résultats au DMS48 des patients aMCI et des patients atteints de MA sont significativement plus faibles que ceux des sujets témoins (set 1 et set 2, p<10−7). Les performances au DMS48 du groupe témoin sont apparues étroitement liées aux données normatives précédemment publiées. Cependant, les performances des patients âgés sont étonnamment plus élevés que les performances attendues des patients jeunes et particulièrement dans le groupe des patients atteints de MA (set 1, 82,2±12,1 et set 2 75,2±16,2). De plus, il y a également une discordance inattendue entre les résultats au DMS48 et au Grober et Buschke RL/RI 16 items. Le DMS48 apparaît utile pour mettre en évidence l’hétérogénéité des syndromes amnésiques des patients MCI et des patients atteints de MA, notamment chez les patients âgées de plus de 75ans : nos résultats soulignent le besoin de la nouvelle caractérisation des troubles cognitifs qui sont de nos jours en croissance au vu de la population vieillissante.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>22405458</pmid><doi>10.1016/j.neurol.2011.11.004</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0035-3787 |
ispartof | Revue neurologique, 2012-06, Vol.168 (6-7), p.483-487 |
issn | 0035-3787 |
language | eng |
recordid | cdi_proquest_miscellaneous_1022377362 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Aged Aged, 80 and over Alzheimer disease (AD) Alzheimer Disease - diagnosis Alzheimer Disease - psychology Cognitive Dysfunction - diagnosis Cognitive Dysfunction - psychology Delayed matching sample DMS 48 Early Diagnosis Educational Status Elderly people Female Free and cued selective reminding test Grober et Buschke RL/RI 16 items Humans Maladie d’Alzheimer Male Memory - physiology Mental Recall - physiology Mild cognitive impairment (MCI) Neuropsychological Tests Patients âgés Recognition (Psychology) - physiology Reproducibility of Results Trouble cognitif léger Visual Perception - physiology |
title | Evaluation of visual recognition memory for the early diagnosis of Alzheimer's disease in patients over 75 years |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A17%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20visual%20recognition%20memory%20for%20the%20early%20diagnosis%20of%20Alzheimer's%20disease%20in%20patients%20over%2075%20years&rft.jtitle=Revue%20neurologique&rft.au=Poissonnet,%20A.&rft.date=2012-06-01&rft.volume=168&rft.issue=6-7&rft.spage=483&rft.epage=487&rft.pages=483-487&rft.issn=0035-3787&rft_id=info:doi/10.1016/j.neurol.2011.11.004&rft_dat=%3Cproquest_cross%3E1022377362%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-6bd004a0e8a1a8fe0162a829b5ae0a52a329bf86a60443d85b2aa88e9c689c5e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1022377362&rft_id=info:pmid/22405458&rfr_iscdi=true |